1Uchibori M,Nishida Y,Tabata I et al.Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction[J].J Rheumatol,2004;31(1):110-119.
2Lu K H,Yang S F,Chu S C.The significance of altered gelatinase expression in the synovium of patient with arthritic effusions[J].Clin Rheumatol,2004;23(1):21-26.
3Dessein P H,Joffe B I,Stanwix A E.High sensitivity C-reactive protein as a disease activity marker in rheumatoid arthritis[J].J Rheumatol,2004;31(6):1095-1097.
4Gillian M,Vera K,Susan A et al.Matrix metalloproteinases in arthritic disease[J].Arthritis Res,2002;4(suppl 3):S39-S49.
5Yoshihara Y H,Nakamura K,Obata H et al.Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis[J].Ann Rheum Dis,2000;59:455-469.
6Gaye C,Oliver F G,Charlotte B et al.Early joint erosions and serum levels of matrix metalloproteinase 1,matrix metalloproteinase 3,and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis[J].Arthritis Rheum,2001;44(10):2263-2274.
7Yamanaka H K,Makino M,Takizawa H et al.Expression and tissue localization of membrane-types 1,2 and 3 matrix metalloproteinases in rheumatoid synovium[J].Lab Invest,2000;80:677-684.
8Giannelli G,Erriquez R,Iannone F et al.MMP-2,MMP-9,TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis[J].Clin Exp Rheumatol,2004;22(3):335-338.
9Kotajima L,Aotsuka S,Fujimani M,et al.Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis[J].Clin Exp Rheumatol,1998,16(4):409-415.
10Zucker S,Mian N,Drews M,et al.Increased serum stromelysin-1 levels in systemic lupus erythematosus:lack of correlation with disease activity[J].J Rheumatol,1999,26(1):78-80.
4Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: epidemiology, social, and economic implica- tions. Kidney Int, 2005,68(Supp 98) : $7-10.
5Johnson TS, Haylor JL, Thomas GL, et al. Matrix metallopro- teinases and their inhibitions in experimental renal scarring. Exp Nephrol,2002,10(3) :182-195.
6Monika Merkle,Andrea Ribeiro,Simone Koppel. TNF-a enhancesTLR3 dependent effects on MMP-9 expression in human mesangial cells[J]. Cell Biology International,2012,36(12):1155-1160.
8BARRATT J, FEEHALLY J. IgA nephropathy [ J ]. J Am Soc Nephrol, 2005,16 : 2088-2097.
9WADA J, SNGIYAMA H, MAKINO H. Pathogenesis of IgA nephropathy [ J ] . Semin Nephrol,2003,23 (6) :556-563.
10BOGENSCHUTZ O, BOHLE A, BATZ C, et al. IgA Nephritis : onthe importance of morphological and clinical parameters in the long oterm prognosis of 239 patients [ J ]. Am J Nephrol, 1990,10: 137.
